6
Participants
Start Date
July 31, 2010
Primary Completion Date
October 31, 2011
Study Completion Date
October 31, 2011
Eculizumab
Dosage/Frequency: 900 mg IV once a week for 4 weeks, 1200 mg IV week 5, then 1200 mg IV every 2 weeks through week 53.
Columbia University Medical Center, Glomerular Center, New York
Columbia University Medical Center, Nephrology Clinical Research Center, New York
Collaborators (1)
Alexion Pharmaceuticals, Inc.
INDUSTRY
Columbia University
OTHER